Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
NYS Entity Status
NYS Filing Date
SEPTEMBER 17, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - BREAD & CHIPS, LLC
AROUND THE WEB
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- This generation’s blue chip stocks are tech companies
By Jonathon Trugman - Sunday Jul 30, 2017
Wall Street has always valued blue chip stocks — a name derived from the highest-value poker chip color — but today’s new blue chips are nothing like your father’s. If there was ever any doubt about what the new blue chips are, last week’s earnings reports cast them in stone. Long forgotten are the “old...
- Panera’s Cups Will Now Tell You How Much Sugar Is In That Fountain Drink
By Mary Beth Quirk - Tuesday Aug 22, 2017
Panera Bread’s health crusade continues apace this week: After launching a new “clean” beverage line and posting calorie and added sugars information for its drinks in its stores, Panera will be rolling out new cups that list nutritional information for every beverage it sells.A spokesperson for Panera tells Consumerist that the new cups will first be launching in …
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]